Abstract
Aortic stiffness is an independent predictor of cardiovascular mortality in a variety of patient groups including hypertensives and other unselected patients. Despite a sound pathophysiologic basis, termed the ventricular-vascular coupling mechanism, the relationship between aortic stiffness and heart failure has been less well studied. This review summarizes some important trials of aortic stiffness in cardiovascular disease risk prediction and progression to heart failure. Emerging targets for therapeutics and areas requiring more research are also discussed.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References and Recommended Reading
Laurent S, Cockcroft J, Van BL, et al.: Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006, 27:2588–2605.
Williams B, Poulter NR, Brown MJ, et al.: Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV. J Hum Hypertens 2004, 18:139–185.
Koelling TM, Chen RS, Lubwama RN, et al.: The expanding national burden of heart failure in the United States: the influence of heart failure in women. Am Heart J 2004, 147:74–78.
Stewart S, MacIntyre K, Capewell S, et al.: Heart failure and the aging population: an increasing burden in the 21st century? Heart 2003, 89:49–53.
Mahomed FA: The etiology of Bright’s disease and the prealbuminuric stage. Transactions of the Medico-Chirurgical Society 1874, 57:197–228.
Lakatta EG, Levy D: Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part I: aging arteries: a “set up” for vascular disease. Circulation 2003, 107:139–146.
Avolio A: Genetic and environmental factors in the function and structure of the arterial wall. Hypertension 1995, 26:34–37.
Avolio AP, Deng FQ, Li WQ, et al.: Effects of aging on arterial distensibility in populations with high and low prevalence of hypertension: comparison between urban and rural communities in China. Circulation 1985, 71:202–210.
Blacher J, Guerin AP, Pannier B, et al.: Impact of aortic stiffness on survival in end-stage renal disease. Circulation 1999, 99:2434–2439.
Laurent S, Boutouyrie P, Asmar R, et al.: Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001, 37:1236–1241.
Meaume S, Benetos A, Henry OF, et al.: Aortic pulse wave velocity predicts cardiovascular mortality in subjects > 70 years of age. Arterioscler Thromb Vasc Biol 2001, 21:2046–2050.
Shoji T, Emoto M, Shinohara K, et al.: Diabetes mellitus, aortic stiffness, and cardiovascular mortality in end-stage renal disease. J Am Soc Nephrol 2001, 12:2117–2124.
Boutouyrie P, Tropeano AI, Asmar R, et al.: Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study. Hypertension 2002, 39:10–15.
Cruickshank K, Riste L, Anderson SG, et al.: Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function? Circulation 2002, 106:2085–2090.
Laurent S, Katsahian S, Fassot C, et al.: Aortic stiffness is an independent predictor of fatal stroke in essential hypertension. Stroke 2003, 34:1203–1206.
Sutton-Tyrrell K, Najjar SS, Boudreau RM, et al.: Elevated aortic pulse wave velocity, a marker of arterial stiffness, predicts cardiovascular events in well-functioning older adults. Circulation 2005, 111:3384–3390.
Shokawa T, Imazu M, Yamamoto H, et al.: Pulse wave velocity predicts cardiovascular mortality: findings from the Hawaii-Los Angeles-Hiroshima study. Circ J 2005, 69:259–264.
Willum-Hansen T, Staessen JA, Torp-Pedersen C, et al.: Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation 2006, 113:664–670.
Mattace-Raso FU, van der Cammen TJ, Hofman A, et al.: Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study. Circulation 2006, 113:657–663.
Safar ME: Epidemiological findings imply that goals for drug treatment of hypertension need to be revised. Circulation 2001, 103:1188–1190.
O’Rourke MF: Diastolic heart failure, diastolic left ventricular dysfunction and exercise intolerance. J Am Coll Cardiol 2001, 38:803–805.
De LN, Asmar RG, London GM, et al.: Selective reduction of cardiac mass and central blood pressure on low-dose combination perindopril/indapamide in hypertensive subjects. J Hypertens 2004, 22:1623–1630.
Williams B, Lacy PS, Thom SM, et al.: Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation 2006, 113:1213–1225.
Roman MJ, Devereux RB, Kizer JR, et al.: Central pressure more strongly relates to vascular disease and outcome than does brachial pressure: the Strong Heart Study. Hypertension 2007, 50:197–203.
Zile MR, Brutsaert DL: New concepts in diastolic dysfunction and diastolic heart failure: part I: diagnosis, prognosis, and measurements of diastolic function. Circulation 2002, 105:1387–1393.
Hundley WG, Kitzman DW, Morgan TM, et al.: Cardiac cycle-dependent changes in aortic area and distensibility are reduced in older patients with isolated diastolic heart failure and correlate with exercise intolerance. J Am Coll Cardiol 2001, 38:796–802.
Kawaguchi M, Hay I, Fetics B, et al.: Combined ventricular systolic and arterial stiffening in patients with heart failure and preserved ejection fraction: implications for systolic and diastolic reserve limitations. Circulation 2003, 107:714–720.
van Heerebeek L, Borbely A, Niessen HW, et al.: Myocardial structure and function differ in systolic and diastolic heart failure. Circulation 2006, 113:1966–1973.
Lakatta EG, Levy D: Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part II: the aging heart in health: links to heart disease. Circulation 2003, 107:346–354.
van Popele NM, Mattace-Raso FU, Vliegenthart R, et al.: Aortic stiffness is associated with atherosclerosis of the coronary arteries in older adults: the Rotterdam Study. J Hypertens 2006, 24:2371–2376.
Mottram PM, Haluska BA, Leano R, et al.: Relation of arterial stiffness to diastolic dysfunction in hypertensive heart disease. Heart 2005, 91:1551–1556.
Mitchell GF, Tardif JC, Arnold JM, et al.: Pulsatile hemodynamics in congestive heart failure. Hypertension 2001, 38:1433–1439.
Mitchell GF, Moye LA, Braunwald E, et al.: Sphygmomanometrically determined pulse pressure is a powerful independent predictor of recurrent events after myocardial infarction in patients with impaired left ventricular function. SAVE investigators. Survival and Ventricular Enlargement. Circulation 1997, 96:4254–4260.
Bonapace S, Rossi A, Cicoira M, et al.: Aortic stiffness correlates with an increased extracellular matrix turnover in patients with dilated cardiomyopathy. Am Heart J 2006, 152:93–96.
Asmar RG, Pannier B, Santoni JP, et al.: Reversion of cardiac hypertrophy and reduced arterial compliance after converting enzyme inhibition in essential hypertension. Circulation 1988, 78:941–950.
Simon AC, Levenson J, Bouthier JD, et al.: Effects of chronic administration of enalapril and propranolol on the large arteries in essential hypertension. J Cardiovasc Pharmacol 1985, 7:856–861.
Topouchian J, Asmar R, Sayegh F, et al.: Changes in arterial structure and function under trandolapril-verapamil combination in hypertension. Stroke 1999, 30:1056–1064.
Girerd X, Giannattasio C, Moulin C, et al.: Regression of radial artery wall hypertrophy and improvement of carotid artery compliance after long-term antihypertensive treatment in elderly patients. J Am Coll Cardiol 1998, 31:1064–1073.
Dhakam Z, McEniery CM, Yasmin et al.: Atenolol and eprosartan: differential effects on central blood pressure and aortic pulse wave velocity. Am J Hypertens 2006, 19:214–219.
Cohn JN: Nitrates versus angiotensin-converting enzyme inhibitors for congestive heart failure. Am J Cardiol 1993, 72:21C–24C.
Van DS, McColl G, Wicks IP: Atorvastatin reduces arterial stiffness in patients with rheumatoid arthritis. Ann Rheum Dis 2004, 63:1571–1575.
Maki-Petaja KM, Hall FC, Booth AD, et al.: Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-alpha therapy. Circulation 2006, 114:1185–1192.
Nakamura T, Matsuda T, Kawagoe Y, et al.: Effect of pioglitazone on carotid intima-media thickness and arterial stiffness in type 2 diabetic nephropathy patients. Metabolism 2004, 53:1382–1386.
Chen SY, Tang WH: Emerging drugs for acute and chronic heart failure: current and future developments. Expert Opin Emerg Drugs 2007, 12:75–95.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cheriyan, J., Wilkinson, I.B. Role of increased aortic stiffness in the pathogenesis of heart failure. Curr Heart Fail Rep 4, 121–126 (2007). https://doi.org/10.1007/s11897-007-0029-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11897-007-0029-y